Aspects between Dengue and COVID-19 coinfection: An integrative literature review

Lucas Costa de Gois, Sabrina Brenda Castelo Branco Silva, Glória Stéphany Silva de Araújo, Kathllyn Joyce de Jesus Oliveira, Bruna Victoria de Sousa Sá, Stálin Santos Damasceno, Alexandre Maslinkiewicz, Julianne de Area Leão Pereira da Silva, Stéfano Vasconcelos Pôrto, Jean Carlos Leal Carvalho de Melo Filho, Júlio César Cardozo Dias, Kleiton Vieira da Silva, Rômulo Gueth Borges do Nascimento, Maria Clara Leite Barros Miranda, Lizandra Ellem Silva de Souza, Gabriel Gardhel Costa Araujo, Idna de Carvalho Barros Taumaturgo

COVID-19, Dengue, Infection, Pandemic, SARS-COV-2.

The disease caused by the new coronavirus (COVID-19), initially investigated in the city of Wuhan, located in China, during 2019 later spread worldwide, affecting millions of individuals, therefore, it triggered the pandemic event, perpetuated with consequences in areas population and economic. However, Dengue is an arboviral pathology with endemic proportions in tropical areas, spread through Aedes aegypti because it spreads the infectious agent. Therefore, the clinical picture emerges that culminates in an increase in body temperature, bleeding events, cephalalgia or pruritus. Thus, the studies were published in the years 2020 to 2021, being the equivalent of 36.36% in the year 2020, and about 63.64% in the year 2021. In this way, the contents of the research found referred to Aspects between Dengue and COVID-19 coinfection. Both have similar clinical manifestations, so their main difference is the respiratory compromise that is more evident in COVID-19.

Received: 07 Aug 2022, Received in revised form: 26 Aug 2022, Accepted: 01 Sep 2022, Available online: 10 Sep 2022

10.22161/ijaers.99.5